Scientific News Boston Scientific Resumes Farapulse Pulsed Field Ablation Study In First Line Afib
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Resumes Farapulse Pulsed Field Ablation Study In First Line Afib is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?
Boston Scientific’s BSX Electrophysiology (“EP”) sales surged 63% in the third quarter of 2025, reflecting continued share gains in the overall EP market. FARAPULSE, the company’s Pulsed Field ... Read More
Brad Sutton on Boston Scientific’s PFA advantage and advice for medtech pros
Boston Scientific Atrial Solutions Chief Medical Officer Dr. Brad Sutton also offered advice for medtech designers and engineers. Read More
Boston Scientific lifts FY25 outlook amid continued cardiovascular boom
Boston achieved a 22.4% growth in its cardiovascular business in Q3, continuing the segment’s growth trend in 2025 due to the ongoing adoption of its Farapulse PFA system. Read More
Boston Scientific continues to win in electrophysiology
Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players. Read More
Newer pulsed field ablation ‘already as effective’ as radiofrequency ablation
Please provide your email address to receive an email when new articles are posted on . AF recurrence after pulsed field ablation was comparable vs. after radiofrequency ablation. There were fewer ... Read More
Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy
Boston Scientific posts strong Q3 growth and upgrades 2025 outlook. See why BSX stock is rated Buy and what drives its leadership. Read More
FARAPULSE™ PFA PLATFORM Team Wins Inaugural Thomas J. Fogarty Innovation Prize
The FARAPULSE team - Allan Zingeler (center), Raju Viswanathan (right center), and Mike Mahoney of Boston Scientific (left center) - were awarded the inaugural Thomas J. Fogarty Innovation Prize by ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus